ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification

Hu, Leihao; He, Canfeng; Mo, Aier; Zhan, Xingkai; Yang, Caizhi; Guo, Wei; Sun, Lingling; Su, Weiwei*; Lin, Lizhu*广州中医药大学; 中山大学; 1
Evidence-based Complementary and Alternative Medicine2023-1-9DOI: 10.1155/2023/3436814
1被引16阅读
引用收藏
分享

摘要

Non-small-cell lung cancer (NSCLC) is one of the most prevalent cancers worldwide. A Yi-Fei-San-Jie formula (YFSJF), widely used in NSCLC treatment in south China, has been validated in clinical studies. However, the pharmacological mechanism behind it remains unclear. In this study, 73 compounds were identified using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), with 58 enrolled in network pharmacology. The protein-protein interaction network, functional enrichment analysis, and compound-target-pathway network were constructed using 74 overlapping targets from 58 drugs and NSCLC. YFSJF has many targets and pathways in the fight against NSCLC. PIK3R1, PIK3CA, and AKT1 were identified as key targets, and the PI3K/AKT pathway was identified as the key pathway. According to the Human Protein Atlas (THPA) database and the Kaplan-Meier Online website, the three key targets had varying expression levels in normal and abnormal tissues and were linked to prognosis. Molecular docking and dynamics simulations verified that hub compounds have a strong affinity with three critical targets. This study revealed multiple compounds, targets, and pathways for YFSJF against NSCLC and suggested that YFSJF might inhibit PIK3R1, PIK3CA, and AKT1 to suppress the PI3K/AKT pathway and play its pharmacological role.

学科与关键词

关键词
PIK3CA MUTATIONSMICROENVIRONMENTADENOCARCINOMACOMBINATIONDECOCTIONPROGNOSISMIGRATIONPATHWAYSACID
相关
加载中…
  • Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation
    Yang, Hongxing; Guo, Qiuyan; Wu, Jianbin; Zhong, Lixia; Sun, Lingling; Liu, Wei; Wang, Jigang*; Lin, Lizhu*Frontiers in Pharmacology, 2022, 13: 851554.被引 2
  • Identification of the active compounds in the Yi-Fei-San-Jie formula using a comprehensive strategy based on cell extraction/UPLC-MS/MS, network pharmacology, and molecular biology techniques
    Hu, Leihao; Luo, Jiamin; Wen, Guiqing; Sun, Lingling; Liu, Wei; Hu, Hao; Li, Jing; Wang, Lisheng*; Su, Weiwei*; Lin, Lizhu*PHYTOMEDICINE, 2023, 115: 154843.
  • Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments
    Peng, Huiting; Huang, Zhongming; Li, Peiqin; Sun, Zhe; Hou, Xuenan; Li, Zeyun; Sang, Ran; Guo, Zehuai; Wu, Siqi; Cao, Yang*Journal of Ethnopharmacology, 2024, 321: 117518.
查看全部 →

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2023-01-09
卷期
第 2023 卷
页码
3436814
DOI
10.1155/2023/3436814
语言
ENGLISH
成果收录
SCIE
资助标注
Collaborative Innovation Research and High-Level Team Building of Integrated Chinese and Western Medicine in Diagnosis and Treatment of Malignant Tumors [2021XK09]; Basic Theoretical Research of Chinese Medicine of the Guangzhou University of Chinese Medicine [[2022]-7]; Cooperative Research of High-Level Hospital Project (Lung Cancer) (2019-2022); National Natural Science Foundation of China [82104647, 81973775]; Postdoctoral Science Foundation of China [2021M700964]

作者

  • H

    Hu, Leihao (第一作者)

    1 · guangzhou univ chinese med

  • H

    He, Canfeng

    1 · guangzhou univ chinese med

查看全部 9 位作者收起作者
  • M

    Mo, Aier

  • Z

    Zhan, Xingkai

    guangzhou univ chinese med

  • Y

    Yang, Caizhi

    1 · guangzhou univ chinese med

  • G

    Guo, Wei

    1 · guangzhou univ chinese med

  • S

    Sun, Lingling

    1 · guangzhou univ chinese med

  • S

    Su, Weiwei (通讯)

    sun yat sen univ

  • L

    Lin, Lizhu (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417